Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ProMIS Neurosciences Inc.
PMN | US
10.15
USD-0.26
-2.50%
PMN | US
Loading StockChartView...
About ProMIS Neurosciences Inc.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
10.15
Open
10.40
High
10.64
Low
9.91
ProMIS Neurosciences Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310 a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267 a TDP-43; and PMN442 a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences Inc. in July 2015. ProMIS Neurosciences Inc. was incorporated in 2004 and is headquartered in Toronto Canada.
View LessPMN | US
Risk
58.6
Sharpe
-0.14
Luna's Score
36/100
Recommendation
Sell
Luna says (PMN | US)
What's Working
Low Market Beta (-0.4 to 0.8)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
46.7%1 month
58.6%3 months
84.3%6 months
96.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
300.04
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-1.74
Ent. to rev.
3.87K
PEG
-
Other Fundamentals
EBITDA
-11.15M
MarketCap
303.34M
MarketCap(USD)
303.34M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-1.10K
Short ratio
1.98
Short perc.
0.56
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.46
Range1M
2.18
Range3M
18.09
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.26
Price X volume
380.93K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.74 | 0.53 | Cheaper |
| Ent. to Revenue | 3,868.08 | 3,967.00 | Par |
| PE Ratio | - | 41.03 | - |
| Price to Book | 300.04 | 15.55 | Expensive |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 84.33 | 72.80 | Par |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 303.34M | 3.66B | Emerging |
